Search Results 141-150 of 28517 for crohns disease

  1. Mayo Clinic Q&A podcast Dr. Faubion IBD

    It's actually quite a common disease. If you take a look at all forms of inflammatory bowel disease, both Crohn's disease and ulcerative colitis, the incidence ...

  2. Vedolizumab IV in Pediatric Participants With Ulcerative Colitis or Crohn's Disease - Mayo Clinic

    ... Crohn's disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

  3. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

    Chronic diarrhea and belly pain could be caused by inflammatory bowel disease. Learn about IBD causes, diagnosis and treatment.

  4. Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease - Mayo Clinic

    Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease · Overview · Participation eligibility · Participating Mayo Clinic ...

  5. Safety and Efficacy of GS-5745 in Participants With Moderately to Severely Active Crohn's Disease - Mayo Clinic

    This study will primarily evaluate the safety and efficacy of GS-5745 in adults with active Crohn's disease. The study will consist of a Blinded Treatment ...

  6. Diarrhea - Mayo Clinic

    Chronic diarrhea can indicate a serious disorder, such as ulcerative colitis or Crohn's disease, or a less serious condition, such as irritable bowel syndrome.

  7. An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease - Mayo Clinic

    This is an investigational study, also known as LATTICE-CD, of the experimental medication BMS-986165 in participants with moderate to severe Crohn's Disease, a ...

  8. Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease - Mayo Clinic

    ... Crohn's disease (CD). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

  9. A Study to Evaluate Effectiveness and Safety of Ustekinumab Re-induction Therapy in Participants With Moderate to Severely Active Crohn's Disease (POWER) - Mayo Clinic

    A Study to Evaluate Effectiveness and Safety of Ustekinumab Re-induction Therapy in Participants With Moderate to Severely Active Crohn's Disease (POWER). Print ...

  10. Small intestinal bacterial overgrowth (SIBO) - Symptoms & causes - Mayo Clinic

    ... problems and some diseases. Sometimes surgery ... Certain medical conditions, including Crohn's disease, radiation enteritis, scleroderma, celiac disease ...